You are invited to an Evening Conference with Panel Discussion & Networking Cocktail hosted by the INSEAD Private Equity Club (IPEC) and the Swiss Healthcare Industry Club (cHIC)

“The Role of Private Equity in Healthcare”

Zunfthaus zur Waag, Zürich on April 2, 2014 from 7 to 10 pm

120

Historically strong returns and low default rates have forged a clear role for private equity in the healthcare sector. For example, two of the largest private equity exits last year were healthcare deals, namely the sale of Bausch and Lomb to Valeant, and the sale of Warner Chilcott to Actavis, each with a valuation of about $8.5 billion. Interest in healthcare provider and services is increasing, while pharma and medtech remain strong. As a result, the competitive environment has become more intense and private equity investors are pursuing more complex deal opportunities, such as those with higher reimbursement and regulatory risk, or assets in need of a turnaround.

Others are aggressively deploying capital around key themes, such as physician consolidation or retail health ventures. Still others target management teams with robust post-acquisition playbooks for longer term investments. In addition, many Western firms seek investments in emerging markets, but they face strong competition there from local firms and strategies.

Our panel of seasoned industry insiders will talk about these strategies in a moderated discussion that is bound to interest and inspire entrepreneurs, corporate finance professionals, as well as investors and life science industry executives.

[warning]Please register before April 1, 2014.[/warning]

You are welcome to invite friends or colleagues along to the event. We look forward to seeing you there!
Kind regards,

Aleksandar Ruzicic, President cHIC
Chandra Leo [MBA D’02], Vice President cHIC
and
Andre Aubert [MBA J’00], President IPEC
Arul Ramadurai (MBA J’05) is the volunteer organizer from IPEC Switzerland

Panelist Bios

Alain Nicod	Managing Partner VI Partners since 2002. Prior to that AlainNicod  (INSEAD MBA ’83) was a shareholder,  board member, and entrepreneur in fast growing companies, including medical instrumentation and IT industries, for example, Compex, LeShop.ch, SourcingParts, Securicard, and MNC. He started his career in 1980 at Arthur Andersen, and then joined McKinsey in 1983. VI Partners is a venture capital investor backed by blue chip companies. He specializes in IT and Life Sciences portfolio companies. Alain Nicod is a board member of two Swiss financial institutions. He earned an MBA from INSEAD after HEC Lausanne.
Juergen Raths	Pharmaceutical Industry Consultant. Most recently, Juergen Raths served as CEO of Correvio, a privately backed Geneva-based specialty pharmaceutical firm. Prior to that, he was CEO of a publicly-traded Basel-based biotechnology company that he led through a merger. His entrepreneurial experience builds on a 20 years international career in medical, sales, marketing and general management in a global pharmaceutical company. Jürgen is MD from the University of Bonn
Ludger Schwinn	Senior Client Partner, Korn/Ferry International since 2002. He has two decades of healthcare experience, particularly in senior executive recruitment for the Life Sciences industry, including the Pharmaceuticals, Biopharmaceuticals, Medical Devices and Diagnostics sectors. He is a key account leader for a number of top global pharmaceutical companies based in Switzerland. He has performed strategic management assessments, as well doing leadership and talent development programs for key clients. Ludger has a Master of Business and Marketing from the University of Basel.
Romain Boichat	Senior Vice-President,Genolier Swiss Medical Network SA since 2012. Romain joined GSMN as Director in 2011. Before that he was with McKinsey and also Director of the Service des automobiles et de la navigation of the state of Vaud. He has served as the Dean of the School of Management of Technology at EPFL. Romain holds an MBA from IMD Lausanne and a PhD from EPFL.
Arul Ramadurai	CEO of ExcellGene SA, a privately-owned Swiss biotechnology provider in the field of protein manufacturing. Prior to that Arul Ramadurai (INSEAD MBA J’05) coached a number of privately-backed enterprises. Before becoming involved in management and leadership of quick growing young company, he worked for 16 years in large corporates in the healthcare and energy industries. Arul is a Chemical Engineer with an MBA from INSEAD.